Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Cyclophosphamide / therapeutic use"'
Autor:
Marko Barešić, Branimir Anić
Publikováno v:
Liječnički vjesnik, Vol 144, Iss 3-411, Pp 112-116 (2022)
Systemic sclerosis is a multisystem autoimmune disorder characterized by widespread fibrosis, primarily of the skin but also of the lung parenchyma. Interstitial lung disease is one of the most severe manifestations of the disease and a leading cause
Externí odkaz:
https://doaj.org/article/aff3e43513fd48e4986f6d3708e75ad2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maher Albitar, Hong Zhang, Andre Goy, Zijun Y. Xu-Monette, Govind Bhagat, Carlo Visco, Alexandar Tzankov, Xiaosheng Fang, Feng Zhu, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, Fredrick B. Hagemeister, Jooryung Huh, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Benjamin M. Parsons, J. Han van Krieken, Miguel A. Piris, Jane N. Winter, Yong Li, Bing Xu, Ken H. Young
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 2, Pp 1-9 (2022)
Blood Cancer Journal, 12
Blood Cancer Journal, 12, 2
Albitar, M, Zhang, H, Goy, A, Xu-Monette, Z Y, Bhagat, G, Visco, C, Tzankov, A, Fang, X, Zhu, F, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, E D, Hagemeister, F B, Huh, J, Ponzoni, M, Ferreri, A J M, Møller, M B, Parsons, B M, van Krieken, J H, Piris, M A, Winter, J N, Li, Y, Xu, B & Young, K H 2022, ' Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms ', Blood Cancer Journal, vol. 12, no. 2, 25 . https://doi.org/10.1038/s41408-022-00617-5
Albitar, M, Zhang, H, Goy, A H, Xu-Monette, Z, Bhagat, G, Visco, C, Tzankov, A, Fang, X, Zhu, F, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, E D, Hagemeister, F B, Huh, J, Ponzoni, M, Ferreri, A J M, Moller, M, Parsons, B M, Van Krieken, J H J M, Piris, M A, Winter, J N, Li, Y, Xu, B & Young, K H 2021, ' Determining Clinical Course of Diffuse Large B-Cell Lymphoma Using Targeted Transcriptome and Machine Learning Algorithms ', Blood, vol. 138, no. Suppl. 1, 2395 . https://doi.org/10.1182/blood-2021-148841
Blood Cancer Journal
Blood Cancer Journal, 12
Blood Cancer Journal, 12, 2
Albitar, M, Zhang, H, Goy, A, Xu-Monette, Z Y, Bhagat, G, Visco, C, Tzankov, A, Fang, X, Zhu, F, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, E D, Hagemeister, F B, Huh, J, Ponzoni, M, Ferreri, A J M, Møller, M B, Parsons, B M, van Krieken, J H, Piris, M A, Winter, J N, Li, Y, Xu, B & Young, K H 2022, ' Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms ', Blood Cancer Journal, vol. 12, no. 2, 25 . https://doi.org/10.1038/s41408-022-00617-5
Albitar, M, Zhang, H, Goy, A H, Xu-Monette, Z, Bhagat, G, Visco, C, Tzankov, A, Fang, X, Zhu, F, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, E D, Hagemeister, F B, Huh, J, Ponzoni, M, Ferreri, A J M, Moller, M, Parsons, B M, Van Krieken, J H J M, Piris, M A, Winter, J N, Li, Y, Xu, B & Young, K H 2021, ' Determining Clinical Course of Diffuse Large B-Cell Lymphoma Using Targeted Transcriptome and Machine Learning Algorithms ', Blood, vol. 138, no. Suppl. 1, 2395 . https://doi.org/10.1182/blood-2021-148841
Blood Cancer Journal
Introduction: Multiple studies have demonstrated that diffuse large B-cell lymphoma (DLBCL) can be divided into subgroups based on their biology. However, these biological subgroups overlap clinically. While R-CHOP (rituximab, cyclophosphamide, doxor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c9ae5e528b2a56ac4958ad97d7f7744
https://doaj.org/article/93888a803eda4609ab485bda57596d9c
https://doaj.org/article/93888a803eda4609ab485bda57596d9c
Autor:
Lasse Hjort Jakobsen, Andreas Kiesbye Øvlisen, Marianne Tang Severinsen, Joachim Bæch, Kristian Hay Kragholm, Ingrid Glimelius, Anne Ortved Gang, Judit Mészáros Jørgensen, Henrik Frederiksen, Christian Bjørn Poulsen, Michael Roost Clausen, Per Trøllund Pedersen, Robert Schou Pedersen, Christian Torp-Pedersen, Sandra Eloranta, Tarec Christoffer El-Galaly
Publikováno v:
Jakobsen, L H, Øvlisen, A K, Severinsen, M T, Bæch, J, Kragholm, K H, Glimelius, I, Gang, A O, Jørgensen, J M, Frederiksen, H, Poulsen, C B, Clausen, M R, Pedersen, P T, Pedersen, R S, Torp-Pedersen, C, Eloranta, S & El-Galaly, T C 2022, ' Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark ', Blood Cancer Journal, vol. 12, no. 1, 16 . https://doi.org/10.1038/s41408-022-00614-8
Blood Cancer Journal
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-7 (2022)
Jakobsen, L H, Øvlisen, A K, Severinsen, M T, Bæch, J, Kragholm, K H, Glimelius, I, Gang, A O, Jørgensen, J M, Frederiksen, H, Poulsen, C B, Clausen, M R, Pedersen, P T, Pedersen, R S, Torp-Pedersen, C, Eloranta, S & El-Galaly, T C 2022, ' Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark ', Blood Cancer Journal, vol. 12, 16 . https://doi.org/10.1038/s41408-022-00614-8
Jakobsen, L H, Ovlisen, A K, Severinsen, M T, Baech, J, Kragholm, K H, Glimelius, I, Gang, A O, Jorgensen, J M, Frederiksen, H, Poulsen, C B, Clausen, M R, Pedersen, P T, Pedersen, R S, Torp-Pedersen, C, Eloranta, S & El-Galaly, T C 2022, ' Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark ', Blood Cancer Journal, vol. 12, no. 1, 16 . https://doi.org/10.1038/s41408-022-00614-8
Blood Cancer Journal
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-7 (2022)
Jakobsen, L H, Øvlisen, A K, Severinsen, M T, Bæch, J, Kragholm, K H, Glimelius, I, Gang, A O, Jørgensen, J M, Frederiksen, H, Poulsen, C B, Clausen, M R, Pedersen, P T, Pedersen, R S, Torp-Pedersen, C, Eloranta, S & El-Galaly, T C 2022, ' Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark ', Blood Cancer Journal, vol. 12, 16 . https://doi.org/10.1038/s41408-022-00614-8
Jakobsen, L H, Ovlisen, A K, Severinsen, M T, Baech, J, Kragholm, K H, Glimelius, I, Gang, A O, Jorgensen, J M, Frederiksen, H, Poulsen, C B, Clausen, M R, Pedersen, P T, Pedersen, R S, Torp-Pedersen, C, Eloranta, S & El-Galaly, T C 2022, ' Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark ', Blood Cancer Journal, vol. 12, no. 1, 16 . https://doi.org/10.1038/s41408-022-00614-8
For most patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL), R-CHOP immunochemotherapy leads to complete remission and 60–70% of patients remain progression-free after 5 years. Given a median age of 65, it is relevant to disentangl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7611d7de63550fde1e34623f58f2393f
https://vbn.aau.dk/ws/files/461184201/Jakobsen_et_al._2022_._Patients_in_complete_remission_after_R_CHOP_like_therapy_for_diffuse_large_B_cell_lymphoma_have_limited_excess_use_of_health_care_services_in_Denmark.pdf
https://vbn.aau.dk/ws/files/461184201/Jakobsen_et_al._2022_._Patients_in_complete_remission_after_R_CHOP_like_therapy_for_diffuse_large_B_cell_lymphoma_have_limited_excess_use_of_health_care_services_in_Denmark.pdf
Autor:
Richard G. Jenner, Tushhar Dadaga, Roger G. Owen, Sally F. Barrington, Matthew Streetly, Marquita Camilleri, William R. Wilson, Rakesh Popat, Jonathan Sive, Gavin Pang, Karthik Ramasamy, Laura Clifton-Hadley, Ceri Bygrave, Elizabeth H Phillips, Kwee Yong, Lucy Pike, James D. Cavenagh, Michael A Chapman
Publikováno v:
British Journal of Haematology
Phillips, E 2020, ' COVID-19 and myeloma clinical research – experience from the CARDAMON clinical trial ', British Journal of Haematology, vol. 192, no. 1, pp. e14-e16 . https://doi.org/10.1111/bjh.17168
Phillips, E 2020, ' COVID-19 and myeloma clinical research – experience from the CARDAMON clinical trial ', British Journal of Haematology, vol. 192, no. 1, pp. e14-e16 . https://doi.org/10.1111/bjh.17168
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8915c71fdd302e6890c68a2c84bf7fee
http://europepmc.org/articles/PMC7753290
http://europepmc.org/articles/PMC7753290
Autor:
Srekar Ravi, Ajay Dhaygude, Brendan Antichos, Phil Seo, Eric J. Gapud, Lauren Floyd, Sam Kant, Duvuru Geetha, Adam D. Morris
Publikováno v:
Floyd, L 2021, ' The impact of COVID-19 pandemic on patients with ANCA associated vasculitis. ', Journal of Nephrology, vol. 34, no. 1, pp. 185-190 . https://doi.org/10.1007/s40620-020-00881-3
Journal of Nephrology
Journal of Nephrology
Introduction The coronavirus 2019 (COVID-19) pandemic has brought on challenges not only to acute care, but also chronic care of patients. Individuals maintained on immunosuppression appear to be especially susceptible to COVID-19 infection. Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa7f0f631a55074dc3c5786e5c9fe240
https://www.research.manchester.ac.uk/portal/en/publications/the-impact-of-covid19-pandemic-on-patients-with-anca-associated-vasculitis(43143b5e-e017-4ce0-9b37-46d96e0815da).html
https://www.research.manchester.ac.uk/portal/en/publications/the-impact-of-covid19-pandemic-on-patients-with-anca-associated-vasculitis(43143b5e-e017-4ce0-9b37-46d96e0815da).html
Autor:
Roger Hesselstrand, Reinhard E. Voll, Ellen De Langhe, Per Ljungman, Jeska K de Vries-Bouwstra, Madelon C. Vonk, Vanessa Smith, Miro Mayer, Anne C. A. Marijnissen, Jacob M van Laar, Nicoletta Del Papa, Karina Roxana Gheorghe, Paco M. W. Welsing, Anna van Rhenen, Dirk M. Wuttge, Roland Schroers, Tessa Kerre, Erik W.A. Marijt, Julia Spierings, Marc Schmalzing, Arjan A. van de Loosdrecht, Joerg Henes, Ulrich A. Walker, Alexandre E Voskuyl, Daan Dierickx
Publikováno v:
BMJ Open, 11
BMJ Open, 11(3). BMJ PUBLISHING GROUP
BMJ Open, 11, 3
BMJ Open, 11(3):e044483. BMJ Publishing Group
BMJ Open, Vol 11, Iss 3 (2021)
BMJ OPEN
Spierings, J, van Rhenen, A, Welsing, P M W, Marijnissen, A C A, de Langhe, E, del Papa, N, Dierickx, D, Gheorghe, K R, Henes, J, Hesselstrand, R, Kerre, T, Ljungman, P, van de Loosdrecht, A A, Marijt, E W A F, Mayer, M, Schmalzing, M, Schroers, R, Smith, V, Voll, R E, Vonk, M C, Voskuyl, A E, de Vries-Bouwstra, J K, Walker, U A, Wuttge, D M & van Laar, J M 2021, ' A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: The UPSIDE study protocol ', BMJ Open, vol. 11, no. 3, e044483 . https://doi.org/10.1136/bmjopen-2020-044483
BMJ Open
BMJ Open, 11(3). BMJ PUBLISHING GROUP
BMJ Open, 11, 3
BMJ Open, 11(3):e044483. BMJ Publishing Group
BMJ Open, Vol 11, Iss 3 (2021)
BMJ OPEN
Spierings, J, van Rhenen, A, Welsing, P M W, Marijnissen, A C A, de Langhe, E, del Papa, N, Dierickx, D, Gheorghe, K R, Henes, J, Hesselstrand, R, Kerre, T, Ljungman, P, van de Loosdrecht, A A, Marijt, E W A F, Mayer, M, Schmalzing, M, Schroers, R, Smith, V, Voll, R E, Vonk, M C, Voskuyl, A E, de Vries-Bouwstra, J K, Walker, U A, Wuttge, D M & van Laar, J M 2021, ' A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: The UPSIDE study protocol ', BMJ Open, vol. 11, no. 3, e044483 . https://doi.org/10.1136/bmjopen-2020-044483
BMJ Open
IntroductionSystemic sclerosis (SSc) is a chronic, autoimmune connective tissue disease associated with high morbidity and mortality, especially in diffuse cutaneous SSc (dcSSc). Currently, there are several treatments available in early dcSSc that a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efe321de3f3691e61f10c0c390a3e5bd
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/232577
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/232577
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
BMJ case reports, vol. 13, no. 1, pp. e231844
BMJ Case Reports
BMJ Case Reports
Multicentric Castleman disease is a rare polyclonal lymphoproliferative disorder mainly associated with two renal manifestations: thrombotic microangiopathy and amyloidosis. Nevertheless, we report here a case of human herpes virus-8 negative multice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69a00e59e6a01a033eda44b26969d3fe
https://serval.unil.ch/notice/serval:BIB_992D4D3B538A
https://serval.unil.ch/notice/serval:BIB_992D4D3B538A